FDA recall D-0006-2016

Diabetes Corporation of America dba DCA Pharmacy · Class II · drug

Product

Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527

Reason for recall

Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.

Distribution

KY, OH, TN

Key facts

Status
Terminated
Initiation date
2015-09-23
Report date
2015-10-14
Termination date
2016-01-12
Voluntary/Mandated
Voluntary: Firm initiated
Location
Franklin, TN, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0006-2016